Please,
1/ for EU submission, are oral mucosal in vitro models accepted by NB for performing In Vitro irritation testing on MD according to ISO 10993-23?? Does any one have any feedback?
2/Can we evaluate the IN vitro cytotoxicity and irritation of a MD in the same time via ISO 10993-23?
3/how can we prepare sample extract for in vitro irritation testing if a MD is not suitable for extraction( a cream product that laboratory said that is hard to extract for extractable testing)?
THANKS in advance for your answer.
1/ for EU submission, are oral mucosal in vitro models accepted by NB for performing In Vitro irritation testing on MD according to ISO 10993-23?? Does any one have any feedback?
2/Can we evaluate the IN vitro cytotoxicity and irritation of a MD in the same time via ISO 10993-23?
3/how can we prepare sample extract for in vitro irritation testing if a MD is not suitable for extraction( a cream product that laboratory said that is hard to extract for extractable testing)?
THANKS in advance for your answer.
Last edited: